Primary retroperitoneal germ cell tumours: Excision via a thoracoabdominal extraperitoneal approach

British Journal of Surgery

Volumn 84, Issue 7, 1997, Pages 1022-1025

  Christmas, T J ^a   Doherty, A P ^a   Rustin, G J S ^b   Seckl, M J ^a   Newlands, E S ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b MOUNT VERNON CANCER CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; METHOTREXATE; VINCRISTINE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; GERM CELL TUMOR; HUMAN; MALE; METASTASIS; PRIORITY JOURNAL; RETROPERITONEAL TUMOR; SURGICAL APPROACH;

ADULT; ALPHA-FETOPROTEINS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHORIONIC GONADOTROPIN; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; GERMINOMA; HUMANS; MALE; MIDDLE AGED; RETROPERITONEAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0030745251     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800840736     Document Type: Article

References (16)

1. Palumbo LT, Cross KR, Smith AN, Baronas AA. Primary teratomas of the lateral retroperitoneal spaces. Surgery 1949; 26: 149-59.
2. Davies JM. Testicular cancer in England and Wales: some epidemiological aspects. Lancet 1981; i: 928-32.
3. Bohle A, Studer UE, Sonntag RW, Scheidegger JR. Primary or secondary extragonadal germ cell tumors? J Urol 1986; 135: 939-43.
4. Logothetis CJ, Samuels ML, Selig DE et al. Chemotherapy of extragonadal germ cell tumors. J Clin Oncol 1985; 3: 316-25.
5. Hitchins RN, Newlands ES, Smith DB, Begent RHJ, Rustin GJS, Bagshawe KD. Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis. Br J Cancer 1989; 59: 236-42.
6. Hendry WF. Abdominal surgery postchemotherapy in metastatic non-seminoma. In: Horwich A, ed. Testicular Cancer - Investigation and Management. London: Chapman and Hall, 1991: 267-85.
7. Newlands ES, Begent RHJ, Rustin GJS, Parker D, Bagshawe KD. Further advances in the management of malignant teratomas of the testis and other sites. Lancet 1983; i: 948-51.
8. Medical Research Council. Prognostic factors in advanced non-seminomatous germ-cell testicular tumours: results of a multicentre study. Report from the Medical Research Council Working Party on Testicular Tumours. Lancet 1985; i: 8-11.
9. Mead GM, Stenning SP, Parkinson MC et al. The second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party. J Clin Oncol 1992; 10: 85-94.
10. Cody HS III, Turnbull AD, Fortner JG, Hajdu SI. The continuing challenge of retroperitoneal sarcomas. Cancer 1981; 47: 2147-52.
11. Logothetis CJ, Samuels ML, Selig DE et al. Cyclic chemotherapy with cyclophosphamidc, doxoruhicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients. Am J Med 1986; 81: 219-28.
12. Tidrick RT, Goldstein MS. Surgical treatment of retroperitoneal tumors. Arch Surg 1955; 70: 203-6.
13. Johnson DE, Laneri JP, Mountain CF, Luna M. Extragonadal germ cell tumors. Surgery 1973; 73: 85-90.
14. Garnick MB, Canellos GP, Richie JP. Treatment and surgical staging of testicular and primary extragonadal germ cell cancer. JAMA 1983; 250: 1733-41.
15. Aparicio J, Montalar J, Munariz EB et al. Extragonadal germ cell tumors: prognostic factors and long-term follow-up. Eur Urol 1995; 28: 19-24.
16. Leiter E, Brendler H. Loss of ejaculation following bilateral retroperitoneal lymphadenectomy. J Urol 1967; 98: 375-8.